Is amyloid beta peptide a driver of inflammaging?
Ageing Research Reviews · 2026-10 · 121 · 103280
DOI: 10.1016/j.arr.2026.103280 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-10. Verfasst von Olga I Kechko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. Electronic address: olga.kechko@eimb.ru. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Aging, Brain, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 372 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Inflammaging, the chronic subclinical systemic inflammation accompanying aging, represents a critical pathogenetic mechanism underlying age-related neurodegenerative diseases. While amyloid beta (Aβ) peptides are established contributors to neuroinflammation in Alzheimer's disease, their role in aging-related subclinical inflammation remains insufficiently elucidated. In humans, Aβ exhibits dual functions: it supports neuronal activity, survival, and protection against neurotrauma, while also promoting inflammation and central nervous system dysfunction. This review highlights the beneficial effects of Aβ, including its antioxidant and antipathogenic properties, and synthesizes current knowledge of the molecular mechanisms driving Aβ-associated inflammaging. We structure this analysis across distinct brain cell types - microglia, astrocytes, oligodendrocytes, neurons, pericytes, and endothelial cells - and consider additional factors influencing Aβ-related neuroinflammation. Finally, we examine strategies to counteract the detrimental effects of Aβ, focusing on Aβ physiological clearance via the blood-brain barrier and glymphatic system, as well as therapeutic interventions. Understanding Aβ-driven inflammaging mechanisms offers new therapeutic avenues for early intervention in age-related neurodegenerative diseases, particularly in genetically susceptible populations. Targeting Aβ-associated inflammaging reframes Aβ not solely as a pathological marker but also as a context-dependent contributor to inflammatory processes during brain aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. Electronic address: olga.kechko@eimb.ru.
- Petrovsky Russian Research Centre of Surgery, Institute of Biology of Aging and Healthy Longevity Medicine with Predictive Medicine Clinic, Moscow, Russia. Electronic address: amoskalev@med.ru.
- Institute of Biogerontology, Lobachevsky State University, Nizhny Novgorod, Russia. Electronic address: claudio.franceschi@unibo.it.
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. Electronic address: mitkevich@eimb.ru.
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. Electronic address: aamakarov@eimb.ru.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Kechko, O. I., Moskalev, A. A., Franceschi, C., Mitkevich, V. A., & Makarov, A. A. (2026). Is amyloid beta peptide a driver of inflammaging?. Ageing Research Reviews, 121, 103280. https://doi.org/10.1016/j.arr.2026.103280
Vancouver
Kechko OI, Moskalev AA, Franceschi C, Mitkevich VA, Makarov AA. Is amyloid beta peptide a driver of inflammaging?. Ageing Research Reviews. 2026;121:103280. doi:10.1016/j.arr.2026.103280
BibTeX
@article{Kechko2026,
author = {Kechko, Olga I and Moskalev, Alexey A and Franceschi, Claudio and Mitkevich, Vladimir A and Makarov, Alexander A},
title = {Is amyloid beta peptide a driver of inflammaging?},
journal = {Ageing Research Reviews},
year = {2026},
volume = {121},
pages = {103280},
doi = {10.1016/j.arr.2026.103280}
}
EUVIMED